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ABSTRACT 
Objective: Pomegranate, (Punica granatum L., Lythraceae) peel has concentrated amounts of lipid-lowering elements that demonstrated, in various 
hoary and recent studies, their effects against obesity and hyperlipidemia, which involves elevated rates of lipid and lipoprotein levels in blood and 
increases risks of cardiovascular diseases. 
We aim to study expression modulation of genes involved in lipid metabolism by the impact of standardized pomegranate peel extract (PPE) in a 
comprehensive research on human liver cells and experimental mice.  
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Methods: Using reverse-transcription real-time PCR, an in vitro study harnessing HepG2 cell line was conducted to determine the hyperlipidemia-
related gene expression profiles and cytotoxic effects upon treatment with PPE. In another complementary in vivo study, male C57BL/6J mice were 
fed a high-fat diet (HFD) or an HFD supplemented with PPE for 14 d to define the expression of lipid metabolism related genes that control obesity. 
Fatty liver proportions were also estimated after treatment. 
Results: Higher mRNA expression of LDL receptor (LDL-R) and down-regulation of sterol regulatory element-binding protein (SREBF-2), (SRBEP-
1c), Fatty acid synthase (FAS) and 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) upon PPE treatment in HepG2 cell line were significantly 
recorded. In vivo study indicated significant weight reduction of body and liver, besides amelioration of fatty liver state detected by histological 
analysis. Moreover, the reverse-transcription real-time PCR assay demonstrated suppression (FAS) expression and up regulation of hormone 
sensitive lipase (HSL) in mice isolated liver and white adipose tissues. 
Conclusion: Our study manages to affirm the hypolipidemic and anti-fatty liver influence of Punica granatum L. peel extract, reflected by molecular 
evaluation above and beyond other physiological assays. 
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INTRODUCTION 
Obesity is a medical condition in which leftover fats of the body  
mass that it may have an undesirable influence on health, leading to 
reduced life expectancy and elevated health difficulties that includes 
hypertension, diabetes, dyslipidemia, and cancers [1]. 
Approximately, half of obesity cases involving visceral fat 
accumulation are compounded by fatty liver, in which triglycerides 
pile in large vacuoles in hepatocytes in a reversible manner. 
Inflammation is occasionally accompanied by the severe fatty liver 
in the situation referred to as steatohepatitis. Nonalcoholic 
steatohepatitis (NASH) develops when inflammation and 
steatohepatitis occur together in non-drinker people [2]. 
An abnormal increase of lipids and lipoproteins such as serum 
triglyceride (TG), total cholesterol and low-density lipoproteins 
(LDL), primarily as a result of some genetic causes or secondarily 
due to other causal roots such as diabetes, is specifically 
characterized and defined as Hyperlipidemia (HL), a specific 
condition of obesity [3-6]. HL is considered as a prime risk factor of 
cardiovascular diseases especially atherosclerosis and ischemic 
heart diseases. An array of reactions beginning with a chemical 
variation of low-density lipoproteins (LDL) in arterial walls through 
oxidation and non enzymatic glycation eventually leads to 
atherosclerotic lesion formation [6-8].  Lipid regulation inside the 
body involves chains of reactions and pathways; each employs 
spectra of enzymes and receptor proteins. Living cells orchestrate 
lipid production, lysis, and intake by managing the expression of 
corresponding genes [9, 10]. Recently, many natural plant-derived 
compounds have been reported as potent antihyperlipidemic agents 
as phototherapeutics’ actively emerges to replace other medications 
of lower effectiveness and higher relative toxicity. Determination of 
gene expression profiles upon treatment with these alternative 
medications provides resolute in-sight evidence [11-13].  
Pomegranate (Family: Lythraceae; scientific name: Punica granatum 
L., Egyptian local name: Romman), an influential medicinal plant 
containing diverse bioactive compounds, was traditionally used in 
the treatment of a wide spectrum of diseases. The ripe fruit is 
laxative, diuretic, tonic, astringent and, used in heart and brain 
diseases, chest troubles, bronchitis and earache [14]. Bark and fruit 
rind are orally administered to avoid bronchitis, dysentery, 
diarrhoea, piles, biliousness and as an anthelmintic [15]. A very high 
efficacy exhibited by pomegranate flowers and fruit extracts was 
reported to reduce circulating lipids and to modify factors of heart 
disease in animals and humans with hyperlipidemia [16, 17]. The 
tannin-rich plant leaf extract demonstrated a strong hypolipidimic 
impact upon oral administration using model animals [18]. 
Besides being highly nutritive, pomegranate peel extract (PPE) is 
known to possess higher content of varied phytochemicals like 
tannins, alkaloids and flavonoids, most of which are observed to 
have therapeutic properties [19, 20]. In previous studies, 
pomegranate peel polyphenolic extract cut down the levels of Total 
Cholesterol/HDL Cholesterol (TC/HDL-c) ratio and serum LDL-c levels 
in hyperlipidemic male Sprague-Dawley (SD) [21] and human [22]. 
Thus, in the present study, the hypolipidemic activity of Punica granatum 
L. peel extract (PPE) was evaluated through determination of gene 
expression levels of lipid metabolism key regulator proteins and 
enzymes behind hyperlipidemia in human liver-derived HepG2 cell line.  
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In addition, we conducted an animal study to investigate the effect of 
on visceral fat levels and hepatic lipid accumulation in mice with diet-
induced obesity. We focused on determination of expression profiles 
of genes related to beta-oxidation and lipogenesis in the liver and 
lipolysis in white adipose tissue after 14 d of PPE oral administration.  
MATERIALS AND METHODS 
Experimental materials 
Cell culture 
Human hepatocarcinoma HepG2 cells were obtained from The 
Holding Company for Biological Products & Vaccines (VACSERA, 
Egypt) and maintained in DMEM supplemented with 10% FBS, 100 
µg streptomycin and 100 units penicillin. Culture conditions were 
adjusted at temperature of 37 °C in a humidified atmosphere 
consisting of 5% CO2 and 95% O2. All used media and reagents were 
purchased from (Lonza Bioproducts, Belgium). Pomegranate fruits 
(Punica granatum L., Lythraceae) was cultivated in Egypt and obtained 
from Sekem farms, Belbeis, Egypt. Standardized Pomegranate Peel 
Extract (PPE), prepared according to [23], was obtained from 
Heliopolis university research lab (Cairo, Egypt). Atos Pharma Co. Ltd. 
(Cairo, Egypt). Standardized PPE contains 3 estimated tannins (gallic 
acid; 11 %, Kaempferol-3-0-glucoside; 1.3% and ellagic acid; 3.4 %) 
and other 3 flavonoids (rutin; 0.5 %), Quercetin; 0.6 %, Pelargonidin; 
0.4 %). All standard preparations were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). 
MTT cytotoxicity assay 
The content of PPE was dissolved in phosphate buffer saline (PBS) to 
a final concentration of 1 mg/ml. The solution was sterile filtered 
using 0.2μm syringe filter units (Nalgene, USA). The cytotoxicity of 
PPE was measured by 3-(4, 5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2Htetrazolium bromide (MTT) in a colorimetric assay as illustrated 
previously [24]. Cell monolayers of 10,000 cells were plated (104 
cells/well) in 96-well tissue culture plate and incubated for 24h at 
37 °C in a humidified incubator with 5 % CO2 to allow attachment of 
cell to the plate except three well without cells as blank, before 
treatment with the PPE in different concentrations (250, 125, 62.5, 
31.2, 15.6, 7.8, 3.9 and 1.6 µg/ml). Then, cells were incubated for 
another 48 h, washed by PBS (Lonza Bioproducts, Belgium) and 50 
µl of MTT (Serva Electrophores, Germany) was added to each well. 
Cells were then incubated in the dark for 4 h for the reduction of 
MTT into formazan followed by addition of 50 μl of Dimethyl 
sulfoxide (DMSO) to solubilize the purple crystals of formazan. 
Absorbance was finally measured at 570 nm with microplate ELISA 
reader (BioTek, USA). The untreated cells were used as a control. 
Control and samples were assayed in quadruplicate for each 
concentration and replicated three times. The percentage of cell 
viability is calculated using the following equation:  
Survival rate %= A 
(sample)−A (negative control)
A (positive control)−A (negative control)
X 100 
Cell treatment with PPE 
The HepG2 cells maintained in DMEM (Lonza Bioproducts, Belgium) 
with no FBS supplementation were treated with PPE at different 
concentrations (25, 50, 100 μg/ml) and incubated for 24, 48 and 72 h. 
Cells were then detached using Trypsin-EDTA (0.05 % trypsin) (Lonza 
Bioproducts, Belgium) and stored at-80 °C until RNA extraction. 
Experimental animals 
Male C57BL/6J albino mice were supplied by Animal Laboratory House 
of Heliopolis University, Cairo, Egypt at the age of six weeks. All animal 
procedures were performed with the approval of the ethical committee 
of the faculty of Pharmacy, Heliopolis University, Cairo, Egypt, issue no# 
HU. REC.1/2016 and the research were conducted in accordance with 
the internationally accepted principles for laboratory animal use and 
care as found in the European Community guidelines [25].  
Mice were housed in polycarbonate animal cages (260 × 420 × 180 
mm; Shanghai Petty International Co., LTD, China) during the 
adaptation period in groups of 4 and administered normal diet (60.6 
% carbohydrates, 10. 5 % fat, 19% protein, 4.3 % fiber, 5 % mineral 
mixture and 0.2% vitamin mixture). During the test period, mice 
were housed in individual stainless steel wire mesh cages (75× 210 
× 150 mm; Shanghai Petty International Co., LTD, China). They were 
held in a controlled environment (25±1.5 °C, 50±1 % humidity), with 
12 h light/dark cycles.  
After 7 d of adaptation, C57BL/6J mice were weighed and divided 
into two groups to obtain a uniform body weight of each group. The 
control group was fed on a high-fat diet (HFD), and the treatment 
group was given the HFD containing 10 % of pomegranate peel 
extract (HFD+PPE). The animals were restricted-fed and given water 
for two weeks. Composition of the HFD per 100 grams was: Corn oil 
(20 g), Casein (20 g), Lard (10 g), Cellulose (4 g), Sucrose (13 g), 
Alpha-potato starch (28.2 g), Mineral mixture, AIN-76 (3.5 g) and 
Vitamin mixture AIN-76 (1.3 g). The oral dose of PPE was set to be 
600 mg per one kilogram of mice weight.  
Body weight and food intake 
During the experiment, animal weights were measured every day. 
Food intake was calculated daily by defining the amount of feed 
remaining from the previous day, and the mean of daily food intake 
for each animal was calculated. 
Measurement of fecal lipids 
All feces were collected daily on days 11–14 after the start of the 
experiment. The collected feces were dried for at least 3 d at 100 ⁰C and 
weighed. After dry feces had been crushed and homogenized, fecal lipids 
were extracted using the Folch extraction protocol [26]. The total lipid 
content was determined by measuring the total dry extract weight. 
Measurement of tissue weight 
Fourteen days after the start of the experiment, mice were sacrificed, 
and then the liver and interscapular brown, mesenteric, epididymal 
and retroperitoneal adipose tissues were removed. All samples were 
weighed. Each sample was cut into small pieces, dipped in Trizol 
reagent (Invitrogen, Carlsbad, CA), and stored at −80  ⁰C until RNA 
extraction. Another piece of each liver sample was stored at −80 ⁰C 
for subsequent analysis. 
Hepatic histological analysis 
Suitable sections of liver were fixed in 10 % formalin and processed 
for preparation of 5 µm-thick paraffin section. These sections were 
sequentially stained with hematoxylin and Eosin (H & E) according 
to Bancroft, Stevens, Dawswon [27] to detect the presence of fat. The 
degree of fatty liver was assessed by expert pathologists and we 
entrusted all analyses to histology lab, Zoology Department, Faculty 
Science, Cairo University. 
Analysis of mRNA expression by real-time reverse 
transcription-polymerase chain reaction (RT-PCR) 
The total RNAs from HepG2 cells, mice liver and epididymal adipose 
tissue were isolated using Trizol reagent (Invitrogen, Carlsbad, CA) 
according to the manufacturer’s instructions. 200 ng of total RNA 
was reverse-transcribed into cDNA in a reaction mixture using a 
TIANscript One-Step reverse transcription-PCR (RT-PCR) kit 
(TIANGEN, China) according to the manufacturer’s directions. The 
gene expression levels were determined using a real-time PCR 
system (5700 applied bio-systems), SYBR Premix Ex Taq (Takara Bio 
Europe, France), and specific sets of primers (table 1) and using 
30cycles of 95 ⁰c for 30 seconds denaturation; the specific annealing 
temperature for 30 seconds; and 72 ⁰C extension for 30 seconds. The 
fold of gene expression level was calculated with real-time PCR Ct-
value relative to glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) HepG2 cell line and Mice. 
Statistical analysis 
All data were expressed as means±standard Error (SE) of a 
minimum duplicate sample for mRNA expression by Real-Time 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and 8 
mice per each mice group (n=8). Data analysis and graph plotting 
were done using GraphPAD Prism package version 5.01 (GraphPAD, 
UK). The statistically significant differences were calculated by 
Students t-test. P values less than 0.05 (P<0.05) were considered as 
indicative of significance. 
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Table 1: Selected HepG2 PCR primer sequences and mice PCR primer sequences 
Gene name Origin Primer sequence (5’-3’) PCR size (bp) Tm (⁰C) 
Sterol regulatory element-binding protein-2 (SREBP-2) HepG2 
 
F-TCTGGAGACCATGGAGACCC 106 60 
R-GTCAGGGAACTCTCCCACTTG 
Hydro-Methyl-GlutarylCoA reductase (HMGCR) HepG2 F-GTTCGGTGGCCTCTAGTGAG 101 60 
R-GGATGGGAGGCCACAAAGAG 
LDL receptor (LDLR) HepG2 F-CAATGTCTCACCAAGCTCTG 258 52 
R-TCTGTCTCGAGGGGTAGCTG 
Sterol regulatory element-binding proteins-1c (SREBP-1c) HepG2 F-GCTGCTGACCGACATCGAA 77 60 
R-GTGGGTCAAATAGGCCAGGG 
Fatty Acid Synthase (FAS) HepG2 F-TATGAAGCCATCGTGGACGG 183 59 
R-GAAGAAGGAGAGCCGGTTGG 
GAPDH HepG2 F-GTCAAGGCTGAGAACGGGAA 158 60 
R-AAATGAGCCCCAGCCTTCTC 
Fatty Acid Synthase (FAS) 
 




Hormone Sensitive Lipase (HSL) 
 
Mice F-CCTACTGCTGGGCTGTCAA 142 58 
R-CCATCTGGCACCCTCACT 










MTT cytotoxicity assay 
The Cytotoxicity of PPE was evaluated by MTT assay and the half 
maximal inhibitory concentration (IC50) values were derived from 
the dose–response curves. The half maximal inhibitory concentration 
(IC50) is a measure of the effectiveness of a compound in inhibiting 
biological or biochemical function. HepG2 human liver carcinoma cells 
were treated with serial dilutions of PPE (2-250 μg/ml). It was clear 
that it decreased the proliferation of HepG2 cells in a concentration-
dependent manner with an IC50 = 115 μg/ml (fig. 1). 
0  
Fig. 1: Determination of PPE cytotoxicity for human liver carcinoma 
HepG2 cell line by using MTT assay. The values are expressed as 
mean±SD (n=3), SD value are too small to be seen on the blot. 
Values were plotted by using GraphPad PRISM program 
(GraphPAD, UK). IC50 (inhibitory concentration 50) = 115 µg/ml 
Food intake; body and tissue weight 
There was a significant decrease between the 2 groups regarding 
final weight, weight gain and; liver weight in favor of HFD+PPE, 
while a non-significant decrease of white and brown adipose tissue 
weights was noticed. Table 2 shows the body weight and amount of 
food intake 14 d after the start of the experiment. 
Analysis of mRNA expression 
As shown in fig. 2, the expression of hepatic genes involved in 
lipogenesis such as LDL-R in the HFD+PPE group was significantly 
higher than that in the HFD group upon PPE treatment with 
concentrations of 50 and 100 µg/ml. Although HMGCR expression 
level decreased using all PPE concentrations, it only decreased 
significantly in the concentration of 100 µg/ml. Fatty Acid Synthase 
(FAS), SREBP-1c and SREBP-2 genes expression decreased 
significantly in PPE concentrations 100 µg/ml. 
The effect of PPE on mRNA expression in mice liver and WAT is 
demonstrated in fig. 3. In liver, FAS was significantly down-
regulated in HFD+PPE group compared to another control group 
of HFD; Hormone Sensitive Lipase (HSL) was up-regulated in a 
significant manner. Acyl Co-A Oxidase levels didn’t significantly 
change however results shown a higher expression in HFD+PPE 
group. In WAT, both FAS mRNA reduced and HSL increased 
significantly. These results suggest that PPE has 
antihyperlipidemic effects in high-fat-diet-induced obese mice 
through suppressing lipogenesis in the liver, stimulating lipolysis 
in liver and WAT. 
  
Table 2: Effects of PFE on food intake, body weight, liver weight, adipose tissue weight, and fecal total lipids 
 HFD HFD+PPE 
Final Weight, g 24.41±0.34 23.22±0.32* 
Weight gain, g 4.07±0.38 2±0.32* 
Food intake, g/day 2.47±0.14 2.5±0.53 
White adipose, g/100 g body weight 2.322±0.23 1.66±0.1 
Brown adipose, g/100 g body weight 0.61±0.72 0.55±0.19 
Liver weight, g 4.99±0.69 3.96±0.14* 
Fecal total Lipids, g/day 0.016±0.001 0.017±0.002 
The data represent the mean±SE values (n = 8).∗ indicates significantly different at P<0.05 against the control group (HFD).  
 
Hepatic histological analysis  
Histopathological investigation of liver tissue slides after 2 w of 
treatment with HFD and HFD+PPE stained with H&E in mice fed on 
HFD showed moderate to severe macrovascular fatty changes, which 
were diffusely distributed throughout the liver lobules. 
Parenchymal inflammation with both acute and chronic 
inflammatory cells accompanying focal necrosis was also 
observed (fig. 4-A and 1-B). In the HFD+PPE group, the 
development of fatty liver was apparently suppressed with 
normal histological change and reduction in fat deposits in liver 
tissues (fig. 4-C, D and E). 
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Fig. 2: HepG2 cell line showed higher expression of LDL 
receptor (LDL-R) and down-regulation of sterol regulatory 
element-binding protein (SREBF-2), (SRBEP-1c), Fatty acid 
synthase (FAS) and 3-hydroxy-3-methylglutaryl-CoA reductase 
(HMGCR) upon PPE treatment. Total mRNAs were extracted 
from cells using Trizol. The relative levels of specific mRNAs 
were assessed by RT-PCR. Results were normalized to GAPDH. 
The data represent the mean±SEM values. ∗ indicate 
significantly different at P<0.05 
 
 
Fig. 3: suppression Fatty acid synthase (FAS) expression and 
upregulation of Hormone-sensitive lipase (HSL) in mice 
isolated liver and white adipose tissues. Total mRNAs were 
extracted from the liver tissues using TRIzol. The relative levels 
of specific mRNAs were assessed by RT-PCR. Results were 
normalized to GAPDH. The data represent the mean±SEM 
values. ∗ indicate significantly different at P<0.05 
 
 
Fig. 4: Histological analysis of the liver (Hematoxylin and 
eosin (H&E) stain). The liver was extracted 14 d after 
commencing the treatment. H&E staining was performed in 
frozen liver sections to detect the presence of fat. These images 
are representative of observations made on 8 mice per group. 
(Scale bar: 50 μm). The liver of mice feeding on HFD; fig. (4; A 
and B) show microvesicular fatty change distributed 
throughout the liver lobules accompanying with focal necrosis 
while the liver of mice feeding on HFD and PPE; fig. (4; C, D and 
E) show normal histological change with reduction in fat 
deposits in liver tissues 
DISCUSSION  
Many natural phytochemicals contained within plant body such as 
Amaranthus Spinosus Leaves [28], Sphaeranthus indicus [29], 
Moringa oleifera leaf [30], Citrullus colocynthis seeds [31], Costus 
speciosus root [32], Cassia auriculata flowers [33], Anethum 
graveolens [34], Rhinacanthus nasutus [35], Roots of Glycyrrhiza 
Glabra, Withania Somnifera roots, Chlorophytum Borivilianum [36], 
phytochemicals such as guggulsterone [37], and luteolin [38] were 
reported to have hypolipidemic activity and ready to become potential 
natural substitutes of other chemical pharmaceutical treatments of 
obesity and hyperlipidemia (e. g. orlistat (Xenical), lorcaserin (Belviq) 
HMG-CoA reductase inhibitors, Bile acid sequestrants, Fibric acid 
derivatives and Nicotinic acid) [39]. 
In our introduced study, HepG2 hepatocarcinoma cells and 
C57BL/6J mice were employed to inspect the regulatory function 
responsible for the hypolipidemic effect of the standardized 
pomegranate peel extract. In order to confine the nontoxic 
concentration of PPE, the MTT assay was performed ranging PPE 
concentrations brought together with HepG2 cells. PPE did not show 
any significant cytotoxicity against HepG2 up to 115 µg/ml, while 
PPE at 250 µg/ml reduced the viability of HepG2 cells to ~25% of the 
untreated control. Punica granatum L. peel extract was proven to 
have lower toxicity levels when compared with a former study that 
also used HepG2 cells to conclude IC50 of 43.75 µg/ml [40]. This 
could be correlated to the standardization procedure conducted on 
the extract to increase the concentration of the active ingredients. 
Hepatic expression of LDL receptor is essential to orchestrate LDL 
cholesterol homeostasis, being a membrane-spanning glycoprotein 
that participates in removing LDL from the blood [41, 42]. Here, PPE 
unregulated LDLR expression in HepG2 cells, beholding accelerated 
clearance of circulating LDL cholesterol. On the other hand, 
mammalian SREBPs encoded by the genes SREBP-1 and SREBF-2 
play an important role in binding to the sterol regulatory element 
DNA sequences [43]. SREBP-1 promotes the transcription of genes 
related to hepatic fatty acid synthesis such as FAS and GPAT [44]. 
SREBP-2 coordinates the activities of enzymes involved in 
cholesterol metabolisms such as HMGCR and SREBP-2 itself [45]. As 
indicated by real-time PCR gene expression assays, PPE didn’t only 
had a significant down-regulation impact on SREBP-1 and SREBF-2, 
those genes that play key role in lipid biosynthesis, but also 
managed to impede transcription of Fatty acid synthase and 
subsequently stemmed the production palmitate, first fatty acid 
produced during fatty acid synthesis and the precursor to longer 
fatty acids [46]. PPE has a significant curbing effect against HMG-coA 
reductase of HepG2 cells, to disrupt cholesterol synthesis in an 
analogous manner if matched to HMG-coA reductase inhibitors (e. g. 
Rosuvastatin, lovastatin, atorvastatin, pravastatin and Fluvastatin). 
Obesity develops when energy intake overreaches energy 
expenditure. PPE supplementation, again, exerted a hypolipidemic 
effect by elevating energy expenditure when significantly lowered 
body weight and body weight gain with no effect on energy intake 
(food intake and fecal lipid content), administered orally to mice for 
two weeks. After estimating expression levels of mice liver and WAT 
lipid homeostasis genes upon PPE intake, results revealed a 
significant suppression of FAS expression, to confirm outcomes 
gleaned over experimentations on HepG2 cells, and a significant up-
regulation of HSL, the predominant lipase effector of catecholamine-
stimulated lipolysis, in both WAT and hepatic tissues.  
However, the insignificant difference in the expression of ACO, the 
enzyme responsible for beta-oxidation, was observed. Our results 
harmonize with another study on Punica granatum L. peel extract 
that showed an obvious decrease in the levels of TC/HDL-c ratio 
and serum LDL-c levels as conducted on male Sprague-Dawley 
(SD) rats [21].  
Development of hepatic steatosis due to the accumulation of free 
fatty acids in the liver is the first step of NASH pathogenesis, a liver 
disease commonly associated with progressive liver disease, fibrosis, 
and cirrhosis. The second step involves additional biochemical 
insults, including oxidative stress, the up-regulation of inflammatory 
mediators, and dysregulated apoptosis [47, 48]. Reduction of risk 
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factors is the main target of current NASH medications that seek 
suppression of hepatic lipid accumulation, the primary step of 
pathogenesis. In the current study, PPE had an evident impact on 
containing fatty liver. Flower extract of pomegranate had a similar 
effect when decreased oil droplets and Triglyceride (TG) content in 
diabetic type II and obese Zucker rats [49]. This may be attributed to 
the common presence of gallic acid in both fruit peel and flower, as 
gallic acid managed to relegate lipid droplet accumulation in mice 
liver, besides significant decline in triglyceride and LDL-cholesterol 
(p<0.05), assayed in a parallel research [50]. Pomegranate flower 
extract was also found to escalate expression of lipolysis-controlling 
genes (peroxisome proliferator-activated receptor PPAR-α and acyl-
CoA oxidase ACO) in HepG2 cells in a recent study [49].  
Kaempferol, this small molecule embraced within PPE, was purified 
from leaves of unripe Jindai-soybean (Edamame) helped to decrease 
SREBP-1c peroxisome proliferator-activated receptor PPAR-γ 
expression in C57BL/6J mice, and then suspected to perform the 
same function in PPE [51]. Other flavonoid phytochemicals enclosed 
in pomegranate peel; ellagic acid, rutin and quercetin enacted lipid 
reduction role in Streptozotocin (STZ)-nicotinamide (NA) induced 
diabetic rat model by the noteworthy diminishing of total 
cholesterol, Triglyceride compared to control rats (p<0.001) [52]. 
CONCLUSION 
Our study explicated the hypolipidemic and anti-fatty liver 
characteristics of standardized PPE; Punica granatum L. peel extract 
through in vitro and in vivo assays. It is well denoted that these 
effects crystallize as a result of lipogenesis suppression and lipolysis 
induction exerted by phytochemicals held within peel structure of 
pomegranate. Further research should focus on delineating more 
molecular events within living cells that lead to these lipid-fighting 
traits of PPE. 
ABBREVIATION 
HFD: High-fat diet; RT-PCR: reverse transcriptase polymerase chain 
reaction. LDL-R: LDL receptor; SREBF: sterol regulatory element-
binding protein; FAS: Fatty acid synthase; HMGCR: 3-hydroxy-3-
methylglutaryl-CoA reductase; HSL: hormone sensitive lipase. 
CONFLICT OF INTERESTS 
The authors declare that they have no conflict of interest. 
REFERENCES 
1. Joo NS, Kim SM, Kim KM, Kim CW, Kim BT, Lee DJ. Changes of 
body weight and inflammatory markers after 12-week 
intervention trial: results of a double-blind, placebo-control 
pilot study. Yonsei Med J 2011;52:242-8. 
2. Ono M, Okamoto N, Saibara T. Prospect of treatment based on 
pathogenesis and epidemiology. Adiposcience 2010;7:68-75. 
3. Eliot LA, Jamali F. Pharmacokinetics, and pharmacodynamics of 
nifedipine in untreated and atorvastatin-treated hyper-
lipidemic rats. J Pharmacol Exp Ther 1999;291:188-93. 
4. Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ. 
The impact of lipoproteins on the biological activity and 
disposition of hydrophobic drugs: implications for drug 
discovery. Nat Rev Drug Discovery. 2008;7:84-99. 
5. Wasan KM, Looije NA. Emerging pharmacological approaches 
to the treatment of obesity. J Pharm Pharm Sci 2005;8:259-71. 
6. Genest J, Frohlich J, Fodor G, McPherson R, Working Group on 
H, Other D. Recommendations for the management of 
dyslipidemia and the prevention of cardiovascular disease: 
summary of the 2003 update. Can Med Assoc J 2003;169:921-4. 
7. Austin MA. Epidemiology of hypertriglyceridemia and 
cardiovascular disease. Am J Cardiol 1999;83:13F-6F. 
8. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, 
et al. Cholesterol and heart disease in older persons and women. 
Review of an NHLBI workshop. Ann Epidemiol 1992;2:161-76. 
9. Ignat'eva EV, Merkulova TI, Vishnevskii OV, Kel AE. 
[Transcriptional regulation of lipid metabolism genes: description 
in the TRDD database]. Molekuliarnaia Biologiia 1997;31:684-700. 
10. Rea TJ, DeMattos RB, Pape ME. Hepatic expression of genes 
regulating lipid metabolism in rabbits. J Lipid Res 1993; 
34:1901-10. 
11. de Jonge JD, Pennings JL, Baken KA, Konings J, Ezendam J, Van 
Loveren H. Gene expression changes in the mesenteric lymph 
nodes of rats after oral peanut extract exposure. J 
Immunotoxicol 2008;5:385-94. 
12. Kim H, Bartley GE, Rimando AM, Yokoyama W. Hepatic gene 
expression related to lower plasma cholesterol in hamsters fed 
high-fat diets supplemented with blueberry peels and peel 
extract. J Agric Food Chem 2010;58:3984-91. 
13. Zhang Y, Li Q, Wan HY, Helferich WG, Wong MS. Genistein and a 
soy extract differentially affect three-dimensional bone 
parameters and bone-specific gene expression in 
ovariectomized mice. J Nutr 2009;139:2230-6. 
14. Middha SK, Usha T, Pande V. A review on antihyperglycemic 
and anti hepatoprotective activity of eco-friendly punica 
granatum peel waste. evidence-based complementary and 
alternative medicine. J Evidence-Based Complementary Altern 
Med 2013. Doi.org/10.1155/2013/656172. [Article in Press] 
15. Priyanka B, Mohd A, Vidhu A, Malay B, Shahnaz S. Antidiabetic 
effect of punica granatum flowers: effect on hyperlipidemia, 
pancreatic cells lipid peroxidation and antioxidant enzymes in 
experimental diabetes. Food Chem Toxicol 2009;47:50-4. 
16. Jafri MA, Aslam M, Javed K, Singh S. Effect of punica granatum 
Linn. (flowers) on blood glucose level in normal and alloxan-
induced diabetic rats. J Ethnopharmacol 2000;70:309-14. 
17. Kaplan M, Hayek T, Raz A, Coleman R, Dornfeld L, Vaya J, et al. 
Pomegranate juice supplementation to atherosclerotic mice 
reduces macrophage lipid peroxidation, cellular cholesterol 
accumulation and development of atherosclerosis. J Nutr 
2001;131:2082-9. 
18. Lei F, Zhang XN, Wang W, Xing DM, Xie WD, Su H, et al. 
Evidence of anti-obesity effects of the pomegranate leaf extract 
in high-fat diet induced obese mice. Int J Obes 2007;31:1023-9. 
19. Aguilar CN, Aguilera-Carbo A, Robledo A. Production of 
antioxidant nutraceuticals by solid-state cultures of 
pomegranate (Punica granatum) peel and creosote bush 
(Larrea tridentata) leaves. Food Technol Biotechnol 
2008;46:218–22. 
20. Middha SK, Usha T, Pande V. A review on antihyperglycemic 
and anti hepatoprotective activity of eco-friendly punica 
granatum peel waste. J Evidence-Based Complementary Altern 
Med 2013. Doi.org/10.1155/2013/656172. [Article in Press] 
21. Cheng S, Guo C, Yang J, Wei J, Li Y, Xu J. Experimental study on 
the hypolipidemic effect of polyphenolic extract from 
pomegranate peel. J Prev Med Chin People's Liberation Army 
2004;3:160–3. 
22. Anoosh E, Mojtaba E, Fatemeh S. Antioxidant activity of juice 
and peel extract of three variety of pomegranate and the effect 
of pomegranate juice on the plasma lipids. Int J Biosci 
2012;2:116-23. 
23. Abdel Motaal A, Shaker S. Anticancer and antioxidant activities 
of standardized whole fruit, pulp, and peel extracts of egyptian 
pomegranate. Open Conf Proc J 2011;211:41-5. 
24. Shin J, Lee HJ, Jung DB, Jung JH, Lee HJ, Lee EO, et al. 
Suppression of STAT3 and HIF-1 alpha mediates antiangiogenic 
activity of betulinic acid in hypoxic PC-3 prostate cancer cells. 
Plos One 2011;6:e21492. Doi:10.1371/journal.pone.0021492. 
[Article in Press] 
25. The Council European Economic Community Directive of 24 
November 1986 on the approximation of laws, regulations and 
administrative provisions of the Member States regarding the 
protection of animals used for experimental and other 
scientific purposes (86/609/EEC); 1986. 
26. Folch J, Lees M, Sloane-Stanley GH. A simple method for the 
isolation and purification of total lipides from animal tissues. J 
Biol Chem 1957;226:497–509. 
27. Bancroft JD, Stevens A, Dawswon MP. Theory and practice of 
histological techniques. 4th ed. Churchill Livingstone, 
Edinbergh, London and New York; 1996. p. 273-92. 
28. Girija K, Lakshman K. Antihyperlipidemic activity of methanol 
extracts of three plants of amaranthus in triton-WR 1339 
induced hyperlipidemic rats. Asian Pac J Trop Dis 2011;1:1-4. 
29. Pande V, Dubey S. Antihyperlipidemic activity of Sphaeranthus 
indicus on atherogenic diet induced hyperlipidemia in rats. Int J 
Green Pharm 2009;2:159-61. 
Zakaria et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 6, 156-161 
161 
30. Adisakwattana S, Chanathong B. Alpha-glucosidase inhibitory 
activity and lipid-lowering mechanisms of moringa oleifera leaf 
extract. Eur Rev Med Pharmacol Sci 2011;15:803-8. 
31. Rahbar AR, Nabipour I. The hypolipidemic effect of Citrullus 
colocynthis on patients with hyperlipidemia. Pak J Biol Sci 
2010;13:1202-7. 
32. Bavarva JH, Narasimhacharya AVRL. Antihyperglycemic and 
hypolipidemic effects of costus speciosus in alloxan induced 
diabetic rats. Phytother Res 2008;22:620-6. 
33. Vijayaraj PS, Muthukumar K, Sabarirajan J, Nachiappan V. 
Evaluation of antihyperlipidemic activity of ethanolic extract of 
Cassia auriculata flowers. Indian J Biochem Biophys. 2011;48:54-8. 
34. Hajhashemi V, Abbasi N. Hypolipidemic activity of anethum 
graveolens in rats. Phytother Res 2008;22:372–5. 
35. Brahma Srinivas Rao Desu, Saileela CH. The anti-
hyperlipidemic activity of methanolic extract of rhinacanthus 
nasutus. Int J Res Pharm Chem 2013;3:708-11. 
36. Nishant P. Ameliorative effects of herbal combinations in 
hyperlipidemia. Oxid Med Cell Longevity 2011:160-408. 
37. Singh K, Chander R, Kapoor NK. Guggulsterone, a potent 
hypolipidaemic, prevents oxidation of low-density lipoprotein. 
Phytother Res 1997;11:291-4. 
38. Liu JF, Ma Y, Wang Y, Du ZY, Shen JK, Peng HL. Reduction of 
lipid accumulation in HepG2 cells by luteolin is associated with 
activation of AMPK and mitigation of oxidative stress. 
Phytother Res 2011;25:588-96. 
39. Kumar V, Fausto N, Abul Abbas. Robbins and cotran 
pathological basics of disease. 7 ed. Elsevier; 2004. 
40. Kumar K, Vijayalakshmi K. In vitro antioxidant activity and 
cytotoxic potential of punica granatum peel and Vitis vinifera 
seeds on hep g2 cell lines. Int J Future Biotechnol 2013;1:1-7. 
41. Sudhof TC, Goldstein JL, Brown MS, Russell DW. The LDL 
receptor gene: a mosaic of exons shared with different 
proteins. Science 1985;228:815-22. 
42. Kovanen PT. Regulation of plasma cholesterol by hepatic low-
density lipoprotein receptors. Am Heart J 1987;113:464-9. 
43. Brown MS, Herz J, Goldstein JL. LDL-receptor structure. 
Calcium cages, acid baths, and recycling receptors. Nature 
1997;388:629-30. 
44. Yokoyama C, Wang XD, Briggs MR, Admon A, Wu J, Hua XX, et 
al. Srebp-1, a basic-helix-loop-helix-leucine zipper protein that 
controls transcription of the low-density lipoprotein receptor 
gene. Cell 1993;75:187-97. 
45. Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, et 
al. SREBP-2, a second basic-helix-loop-helix-leucine zipper 
protein that stimulates transcription by binding to a sterol 
regulatory element. Proc Natl Acad Sci USA 1993;90:11603-7. 
46. Gunstone FD, Harwood L, Dijkstra. The lipid handbook with Cd-
Rom. Boca Raton: 3 ed. CRC Press; 2007. 
47. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review 
and update. Dig Dis Sci 2010;55:560-78. 
48. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. 
Nonalcoholic steatohepatitis: recent advances from 
experimental models to clinical management. Clin Biochem 
2005;38:203-17. 
49. Xu KZ, Zhu C, Kim MS, Yamahara J, Li Y. Pomegranate flower 
ameliorates fatty liver in an animal model of type 2 diabetes 
and obesity. J Ethnopharmacol 2009;123:280-7. 
50. Jang A, Srinivasan P, Lee NY, Song HP, Lee JW, Lee M, et al. 
Comparison of hypolipidemic activity of synthetic gallic acid 
linoleic acid ester with a mixture of gallic acid and linoleic acid, 
gallic acid, and linoleic acid on high-fat diet induced obesity in 
C57BL/6 Cr Slc mice. Chem Biol Interact 2008;174:109-17. 
51. Zang Y, Zhang L, Igarashi K, Yu C. The anti-obesity and anti-
diabetic effects of kaempferol glycosides from unripe soybean 
leaves in high-fat-diet mice. Food Function 2015;6:834-41. 
52. Jadhav R, Puchchakayala G. Hypoglycemic and antidiabetic 
activity of flavonoids: boswellic acid, ellagic acid, quercetin, 
rutin on streptozotocin-nicotinamide induced type 2 diabetic 
rats. Int J Pharm Pharm Sci 2012;4:251-6.  
 
